# Aytu BioPharma (AYTU): Shareholder Alert: Ademi LLP, a 46.2% Day

> Source: IndicatorStack, https://indicatorstack.com/catalysts/aytu-2026-11-17-release. Updated Nov 19, 2026, 4:28 AM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

Aytu BioPharma (AYTU) announced shareholder Alert: Ademi LLP at 8:55 AM ET on Tuesday, November 17, and the stock went from Monday’s $1.82 close to as high as $2.67 before the open. It finished the session +46.2% at $2.66 on 44.7 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.

Catalyst Reaction by IndicatorStack, published Nov 19, 2026, 4:11 AM ET. NASDAQ: AYTU, Drug Manufacturers - Specialty & Generic. All times ET.

## The numbers

- +46.2% Tuesday’s close ($1.82 to $2.66, high $2.67)
- 44.7× its 20-day average volume (4.4M shares on the day)
- 8:55 AM the catalyst crossed, ET (Tuesday, before the open)
- 10M float, shares (44% of the float traded on Tuesday)

## How the stack read it, checkpoint by checkpoint

| Checkpoint | When | Price | 5m stack bias | Compass |
| --- | --- | --- | --- | --- |
| Before | Mon close | $1.80 | Bullish, weakening | 15m and 1h split |
| Into the open | Tue 9:30 AM | $2.67 | Bullish, firm | 15m and 1h up |
| 30 minutes in | Tue 10:00 AM | $2.66 | Bullish, weakening | 15m and 1h up |
| At the close | Tue 4:00 PM | $2.65 | Neutral | 15m and 1h up |
| Wednesday’s close | Wed 4:00 PM | $2.66 | Neutral | 15m and 1h up |

## Timeline

### Monday, November 16

- 4:03 PM: Current report (Form 8-K) filed (Accepted by the SEC at 4:03:17 PM ET)
- 4:11 PM: Rosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansion (Press release, GlobeNewsWire)
- 4:17 PM: Current report (Form 8-K) filed (Accepted by the SEC at 4:17:18 PM ET)
- 4:23 PM: Quarterly report (Form 10-Q) filed (Accepted by the SEC at 4:23:52 PM ET)

### Tuesday, November 17

- 8:55 AM: Shareholder Alert: Ademi LLP (Press release, GlobeNewsWire)
- 9:20 AM: Premarket high $2.67 (+46.7% from the prior close)
- 9:30 AM: Opened at $2.66 (+46.2% from Monday’s $1.82 close)
- 10:30 AM: Session low $2.65
- 10:48 AM: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying investors of the (Press release, GlobeNewsWire)
- 2:45 PM: 5-minute stack bias turned bearish (at $2.65)
- 3:25 PM: 5-minute stack bias went neutral (at $2.66, its inputs no longer agreeing)
- 4:00 PM: Closed at $2.66, +46.2% on the day (4.4M shares, 44.7× its 20-day average)

### Wednesday, November 18

- 9:30 AM: Session low $2.65
- 9:30 AM: Opened at $2.65 (−0.4% from Tuesday’s $2.66 close)
- 11:20 AM: 5-minute stack bias turned bullish (at $2.66)
- 12:00 PM: 5-minute stack bias went neutral (at $2.65, its inputs no longer agreeing)
- 4:00 PM: Closed at $2.66, +0.0% on the day (376K shares, 1.2× its 20-day average)

## Before the catalyst (Monday, November 16)

Aytu BioPharma closed Monday at $1.82. The 5-minute stack bias was bullish (weakening), since 11:00 AM: momentum up. Compass read “15m and 1h split” (15m ↗ 1h ↓ 2h ↓ 4h ↓ D ↘). Undertow: buying drying up, sellers absorbing the pushes. Tripwire: Longs: Caution, against the daily and weekly cycle. Its Next row read “Lost VWAP 1.80, buyers need a reclaim”.

Over the year before, it had traded between $1.75 and $3.07.

## The release and a 46.2% session (Tuesday, November 17)

The release crossed at 8:55 AM ET. It opened at $2.66, +46.2%, and the regular session ranged from $2.65 to $2.67 before closing at $2.66. It did this on a day SPY fell 1.0% and XLV, the drug manufacturers - specialty & generic ETF, fell 1.4%.

Into the open the stack read it as bullish (firm) with 2 of 2 higher timeframes up, and Undertow read “thin tape”. Thirty minutes in, the picture had changed: price held above VWAP at $2.65 and the Next row read “Pullback, support to hold at 2.66 (slow EMA)”. By the close the 5-minute bias was neutral, while Compass still read “15m and 1h up”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.

## The session after (Wednesday, November 18)

It opened at $2.65 (−0.4%) and traded from $2.65 to $2.66, closing at $2.66, +0.0% on 376K shares, still 1.2 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h up” (15m ↗ 1h ↑ 2h ↑ 4h ↑ D ↑). Undertow: sellers lead, no large size yet. Tripwire: Longs: Clean, nothing major in the way.

After hours it last traded at $2.66, with Undertow reading “hidden selling”.

## Supply

|  |  |  |
| --- | --- | --- |
| Shares outstanding | 10.9M | as reported to the SEC |
| Float | 10M | 92% of shares outstanding |
| Reverse splits on record | 7 | 1-for-20 reverse split, January 6, 2023; 1-for-10 reverse split, December 9, 2020; 1-for-20 reverse split, August 13, 2018; 1-for-20 reverse split, August 29, 2017; 1-for-12 reverse split, October 28, 2016; 1-for-12 reverse split, July 1, 2016; 41-for-500 reverse split, June 10, 2015 |
| Last insider purchase | November 18, 2020 | 10K shares at $0.9230 by DOCKERY CARL (director) |
| Last insider sale | December 30, 2020 | 209 shares at $6.01 |

## Sources

- Tue Nov 17, 10:48 AM ET, Press release: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying investors of the (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/17/3404982/0/en/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-aytu-biopharma-inc-nasdaq-aytu-rapid-micro-biosystems-inc-nasdaq-rpid-advantage-energy-ltd-otc-.html
- Tue Nov 17, 8:55 AM ET, Press release: Shareholder Alert: Ademi LLP (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/17/3404635/884/en/aytu-shareholder-alert-ademi-llp-investigates-whether-buyout-fairly-values-aytu-biopharma-inc.html
- Mon Nov 16, 4:23 PM ET, SEC filing: Quarterly report (Form 10-Q) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1385818/000143774926037188/aytu20260930_10q.htm
- Mon Nov 16, 4:17 PM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1385818/000143774926037176/ex_1043333.htm
- Mon Nov 16, 4:11 PM ET, Press release: Rosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansion (GlobeNewsWire) https://www.globenewswire.com/news-release/2026/11/16/3404140/0/en/rosemont-pharmaceuticals-to-acquire-aytu-biopharma-to-accelerate-us-expansion.html
- Mon Nov 16, 4:03 PM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1385818/000143774926037155/aytu20261113_8k.htm

## Questions

### Why did AYTU stock go up on November 17?

AYTU finished the session +46.2% at $2.66 on 44.7 times its 20-day average volume. The timeline lists every release and filing around the move, each timed to the minute. The reaction describes the sequence and infers no cause.

### What did Aytu BioPharma announce on November 17, 2026?

Aytu BioPharma (AYTU) announced shareholder Alert: Ademi LLP at 8:55 AM ET on Tuesday, November 17.

### How did AYTU stock trade on November 17?

AYTU opened at $2.66, +46.2% from the prior close of $1.82, traded between $2.65 and $2.67 in the regular session and closed at $2.66, +46.2%, on 4.4M shares.

### How did LiveChart’s stack read AYTU at the close on November 17?

At the 4:00 PM ET close the 5-minute stack bias on AYTU was neutral, Compass read “15m and 1h up” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.

### What does LiveChart’s stack read on AYTU now?

The read on this page is fixed at each moment it describes. LiveChart reads AYTU on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.

Chart: https://indicatorstack.com/chart/AYTU. AYTU catalyst history: https://indicatorstack.com/catalysts/stock/AYTU

Each reaction describes what happened and when, infers no cause and takes no view on what comes next. Past reactions don’t predict future ones.

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
